A new publication involving lanreotide was announced on September 1, 2026. The paper, titled "Targeting autolysin ATL of Streptococcus suis: structural insights and inhibition by lanreotide acetate," appears in The Journal of Antimicrobial Chemotherapy.
The publication is listed under PubMed ID 42770615. Lanreotide is an approved compound, and this entry reflects a new piece of scientific literature referencing lanreotide acetate in connection with the ATL autolysin of Streptococcus suis.
No specific findings, results, or conclusions from the publication are detailed here. This brief reports only that the publication exists, its title, its journal, and its listed date. Readers seeking the content of the study, including any structural or inhibition data discussed by the authors, should consult the original source directly.
For additional background on lanreotide, including its approved uses and general profile, readers can refer to the compound overview.